Dawn-bio ApS: Financial statements 2024
CVR: 43849662
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Dawn-bio ApS (CVR 43849662) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,208,662 and a net result of DKK -1,568,059 compared with DKK -785,330 the year before. Equity in the 2024 report amounted to DKK -2,313,389. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,208,662
- Profit/Loss
- DKK -1,568,059
- Equity
- DKK -2,313,389
- Total Assets
- DKK 2,011,617
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1.2M | -1.6M | -2.3M | 1 |
| 2023 | - | -562K | -785K | -745K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Dawn-bio ApS has published its interim report for the period February 13, 2023 to December 31, 2023.
About Dawn-bio ApS
Dawn-bio ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Greiner and Alok Javali. The company is owned by dawn-bio GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -638,228 and a net result of DKK -1,121,090 compared with DKK -1,568,059 the year before. Equity in the 2025 report amounted to DKK -3,434,479.